Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 726723, 13 pages
http://dx.doi.org/10.1155/2011/726723
Review Article

Traditional Chinese Medicines in Treatment of Patients with Type 2 Diabetes Mellitus

1Life Science Division, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China
2Laboratory of Pathological Sciences, Basic Medical College, Nanjing University of Traditional Chinese Medicine, Nanjing 210029, China

Received 11 August 2010; Revised 16 December 2010; Accepted 19 January 2011

Copyright © 2011 Weidong Xie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. S. Ali, M. F. Linton, and S. Fazio, “Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 15, no. 2, pp. 142–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Xie, D. Xing, Y. Zhao et al., “A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transit,” European Journal of Pharmacology, vol. 510, no. 1-2, pp. 113–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Xie and L. Du, “High-cholesterol diets impair short-term retention of memory in alloxan-induced diabetic mice, but not acquisition of memory nor retention of memory in prediabetic mice,” Life Sciences, vol. 77, no. 5, pp. 481–495, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. W. D. Xie, Y. Nie, L. J. Du, Y. O. Zhang, and G. P. Cai, “Preventive effects of fenofibrate and vitamin C on the development of type 2 diabetes and its complications in NIH mice induced by small-dose streptozotocin and lard,” Pharmacological Research, vol. 55, pp. 392–399, 2007. View at Google Scholar
  5. W. Jia, W. Gaoz, and L. Tang, “Antidiabetic herbal drugs officially approved in China,” Phytotherapy Research, vol. 17, no. 10, pp. 1127–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. W. L. Li, H. C. Zheng, J. Bukuru, and N. De Kimpe, “Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 1–21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Liu, M. Zhang, W. Y. Wang, and S. Grimsgaard, “Chinese herbal medicines for type 2 diabetes mellitus,” Cochrane Database of Systematic Reviews, no. 3, article CD003642, 2004. View at Google Scholar · View at Scopus
  8. W. Xie, D. Xing, H. Sun, W. Wang, Y. Ding, and L. Du, “The effects of Ananas comosus L. leaves on diabetic-dyslipidemic rats induced by alloxan and a high-fat/high-cholesterol diet,” American Journal of Chinese Medicine, vol. 33, no. 1, pp. 95–105, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Xie, Y. Zhang, N. Wang et al., “Novel effects of macrostemonoside A, a compound from Allium macrostemon Bung, on hyperglycemia, hyperlipidemia, and visceral obesity in high-fat diet-fed C57BL/6 mice,” European Journal of Pharmacology, vol. 599, no. 1–3, pp. 159–165, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. W. D. Xie, Y. N. Zhao, L. J. Du, G. P. Cai, D. Y. Gu, and Y. O. Zhang, “Scorpion in combination with Gypsum: novel antidiabetic activities in streptozotocin-induced diabetic mice by up-regulating pancreatic PPARγ and PDX-1 expressions,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  11. V. Vuksan, J. L. Sievenpiper, Z. Xu et al., “Konjac-mannan and American ginseng: emerging alternative therapies for type 2 diabetes mellitus,” Journal of the American College of Nutrition, vol. 20, no. 5, supplement, pp. 370S–380S, 2001. View at Google Scholar
  12. E. A. Sotaniemi, E. Haapakoski, and A. Rautio, “Ginseng therapy in non-insulin-dependent diabetic patients,” Diabetes Care, vol. 18, no. 10, pp. 1373–1375, 1995. View at Google Scholar · View at Scopus
  13. V. Vuksan, J. L. Sievenpiper, V. Y. Y. Koo et al., “American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus,” Archives of Internal Medicine, vol. 160, no. 7, pp. 1009–1013, 2000. View at Google Scholar · View at Scopus
  14. S. W. Ma, I. F. F. Benzie, T. T. W. Chu, B. S. P. Fok, B. Tomlinson, and L. A. H. Critchley, “Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trial,” Diabetes, Obesity and Metabolism, vol. 10, no. 11, pp. 1125–1127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Vuksan, M. K. Sung, J. L. Sievenpiper et al., “Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 18, no. 1, pp. 46–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Y. Guo, H. Q. Cai, T. Wang, X. J. Zhang, and H. Shen, “Renshen tangtai injection in treatment of 30 cases of type 2 diabetes mellitus,” Jilin Da Xue Xue Bao, vol. 29, pp. 206–207, 2003 (Chinese). View at Google Scholar
  17. J. L. Reay, A. B. Scholey, A. Milne, J. Fenwick, and D. O. Kennedy, “Panax ginseng has no effect on indices of glucose regulation following acute or chronic ingestion in healthy volunteers,” British Journal of Nutrition, vol. 101, no. 11, pp. 1673–1678, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. B. X. Wang, M. Yang, Y. L. Jin, Z. Y. Cui, and Y. Wang, “Studies on the hypoglycemic effect of ginseng polypeptide,” Acta Pharmaceutica Sinica, vol. 25, no. 6, pp. 401–405, 1990 (Chinese). View at Google Scholar · View at Scopus
  19. J. T. Xie, J. A. Wu, S. Mehendale, H. H. Aung, and C. S. Yuan, “Anti-hyperglycemic effect of the polysaccharides fraction from American ginseng berry extract in ob/ob mice,” Phytomedicine, vol. 11, no. 2-3, pp. 182–187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Kim, M. Park, and H. Y. Kim, “Ginsenoside Rg3 suppresses palmitate-induced apoptosis in MIN6N8 pancreatic β-cells,” Journal of Clinical Biochemistry and Nutrition, vol. 46, no. 1, pp. 30–35, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Shang, Y. Yang, L. Zhou, B. Jiang, H. Jin, and M. Chen, “Ginsenoside Rb stimulates glucose uptake through insulin-like signaling pathway in 3T3-L1 adipocytes,” Journal of Endocrinology, vol. 198, no. 3, pp. 561–569, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Z. Luo and L. Luo, “Ginseng on hyperglycemia: effects and mechanisms,” Evidence-Based Complementary and Alternative Medicine, vol. 6, pp. 423–427, 2009. View at Google Scholar
  23. J. Yin, H. Xing, and J. Ye, “Efficacy of berberine in patients with type 2 diabetes mellitus,” Metabolism, vol. 57, no. 5, pp. 712–717, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Chen, Y. Zhang, and C. Huang, “Berberine inhibits PTP1B activity and mimics insulin action,” Biochemical and Biophysical Research Communications, vol. 397, no. 3, pp. 543–547, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Yin, Z. Gao, D. Liu, Z. Liu, and J. Ye, “Berberine improves glucose metabolism through induction of glycolysis,” American Journal of Physiology, vol. 294, no. 1, pp. E148–E156, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Yu, L. Liu, X. Wang et al., “Modulation of glucagon-like peptide-1 release by berberine: in vivo and in vitro studies,” Biochemical Pharmacology, vol. 79, no. 7, pp. 1000–1006, 2010. View at Google Scholar · View at Scopus
  27. J. Zhou, S. Zhou, J. Tang et al., “Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats,” European Journal of Pharmacology, vol. 606, no. 1–3, pp. 262–268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Liu, Y. L. Yu, J. S. Yang et al., “Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 381, no. 4, pp. 371–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Ahmad, M. R. Hassan, H. Halder, and K. S. Bennoor, “Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients,” Bangladesh Medical Research Council Bulletin, vol. 25, no. 1, pp. 11–13, 1999. View at Google Scholar · View at Scopus
  30. E. Basch, S. Gabardi, and C. Ulbricht, “Bitter melon (Momordica Charantia): a review of efficacy and safety,” American Journal of Health-System Pharmacy, vol. 60, no. 4, pp. 356–359, 2003. View at Google Scholar · View at Scopus
  31. M. J. Tan, J. M. Ye, N. Turner et al., “Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway,” Chemistry and Biology, vol. 15, no. 3, pp. 263–273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. B. Krawinkel and G. B. Keding, “Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia,” Nutrition Reviews, vol. 64, no. 7, pp. 331–337, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. W. D. Xie and L. J. Du, “Diabetes is an inflammatory disease: evidences fromtraditional Chinese medicines,” Diabetes, Obesity and Metabolism, vol. 13, no. 4, pp. 289–301, 2011. View at Publisher · View at Google Scholar
  34. P. Khanna, S. C. Jain, A. Panagariya, and V. P. Dixit, “Hypoglycemic activity of polypeptide-p from a plant source,” Journal of Natural Products, vol. 44, no. 6, pp. 648–655, 1981. View at Google Scholar · View at Scopus
  35. E. Basch, S. Gabardi, and C. Ulbricht, “Bitter melon (Momordica Charantia): a review of efficacy and safety,” American Journal of Health-System Pharmacy, vol. 60, no. 4, pp. 356–359, 2003. View at Google Scholar · View at Scopus
  36. C. P. Ooi, Z. Yassin, and T. A. Hamid, “Momordica charantia for type 2 diabetes mellitus,” Cochrane Database of Systematic Reviews, vol. 2, article CD007845, 2010. View at Google Scholar · View at Scopus
  37. A. Gupta, R. Gupta, and B. Lal, “Effect of Trigonella foenum-graecum (Fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study,” Journal of Association of Physicians of India, vol. 49, pp. 1057–1061, 2001. View at Google Scholar · View at Scopus
  38. D. Puri, “Fenugreek in diabetes mellitus,” The Journal of the Association of Physicians of India, vol. 47, no. 2, pp. 255–256, 1999. View at Google Scholar · View at Scopus
  39. Z. Madar, R. Abel, S. Samish, and J. Arad, “Glucose-lowering effect of fenugreek in non-insulin dependent diabetics,” European Journal of Clinical Nutrition, vol. 42, no. 1, pp. 51–54, 1988. View at Google Scholar · View at Scopus
  40. N. Kassaian, L. Azadbakht, B. Forghani, and M. Amini, “Effect of Fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients,” International Journal for Vitamin and Nutrition Research, vol. 79, no. 1, pp. 34–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. F. R. Lu, L. Shen, Y. Qin, L. Gao, H. Li, and Y. Dai, “Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus,” Chinese Journal of Integrative Medicine, vol. 14, no. 1, pp. 56–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Moorthy, K. M. Prabhu, and P. S. Murthy, “Anti-hyperglycemic compound (GII) from fenugreek (Trigonella foenum-graecum Linn.) seeds, its purification and effect in diabetes mellitus,” Indian Journal of Experimental Biology, vol. 48, pp. 1111–1118, 2010. View at Google Scholar
  43. T. Uemura, S. Hirai, N. Mizoguchi et al., “Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues,” Molecular Nutrition and Food Research, vol. 54, no. 11, pp. 1596–1608, 2010. View at Publisher · View at Google Scholar
  44. A. B. Singh, A. K. Tamarkar, . Shweta, T. Narender, and A. K. Srivastava, “Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice,” Natural Product Research, vol. 24, no. 3, pp. 258–265, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. F. R. Lu, L. Shen, Y. Qin, L. Gao, H. Li, and Y. Dai, “Clinical observation on trigonella foenum-graecum L. total saponins in combination with sulfonylureas in the treatment of type 2 diabetes mellitus,” Chinese Journal of Integrative Medicine, vol. 14, no. 1, pp. 56–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Hamden, H. Masmoudi, S. Carreau, and A. Elfeki, “Immunomodulatory, β-cell, and neuroprotective actions of fenugreek oil from alloxan-induced diabetes,” Immunopharmacology and Immunotoxicology, vol. 32, no. 3, pp. 437–445, 2010. View at Publisher · View at Google Scholar
  47. J. M. A. Hannan, L. Ali, B. Rokeya et al., “Soluble dietary fibre fraction of Trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action,” British Journal of Nutrition, vol. 97, no. 3, pp. 514–521, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Puri, K. M. Prabhu, and P. S. Murthy, “Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds,” Indian Journal of Physiology and Pharmacology, vol. 46, no. 4, pp. 457–462, 2002. View at Google Scholar · View at Scopus
  49. A. M. Flammang, M. A. Cifone, G. L. Erexson, and L. F. Stankowski, “Genotoxicity testing of a fenugreek extract,” Food and Chemical Toxicology, vol. 42, no. 11, pp. 1769–1775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Abebe, “Herbal medication: potential for adverse interactions with analgesic drugs,” Journal of Clinical Pharmacy and Therapeutics, vol. 27, no. 6, pp. 391–401, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Sitprija, C. Plengvidhya, V. Kangkaya, S. Bhuvapanich, and M. Tunkayoon, “Garlic and diabetes mellitus phase II clinical trial,” Journal of the Medical Association of Thailand, vol. 70, supplement 2, pp. 223–227, 1987. View at Google Scholar · View at Scopus
  52. R. Ashraf, K. Aamir, A. R. Shaikh, and T. Ahmed, “Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus,” Journal of Ayub Medical College, vol. 17, no. 3, pp. 60–64, 2005. View at Google Scholar · View at Scopus
  53. I. A. Sobenin, L. V. Nedosugova, L. V. Filatova, M. I. Balabolkin, T. V. Gorchakova, and A. N. Orekhov, “Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study,” Acta Diabetologica, vol. 45, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. C. T. Liu, H. Hse, C. K. Lii, P. S. Chen, and L. Y. Sheen, “Effects of garlic oil and diallyl trisulfide on glycemic control in diabetic rats,” European Journal of Pharmacology, vol. 516, no. 2, pp. 165–173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Hattori, N. Yamada, T. Nishikawa, H. Fukuda, and T. Fujino, “Antidiabetic effects of ajoene in genetically diabetic KK-A mice,” Journal of Nutritional Science and Vitaminology, vol. 51, no. 5, pp. 382–384, 2005. View at Google Scholar · View at Scopus
  56. K. T. Augusti and C. G. Sheela, “Antiperoxide effect of S-allyl cysteine sulfoxide, an insulin secretagogue, in diabetic rats,” Experientia, vol. 52, no. 2, pp. 115–119, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. J. J. Zhang, “Physiological function of garlic,” Zhongguo Shi Wu Yu Ying Yang, vol. 5, pp. 45–47, 2006 (Chinese). View at Google Scholar
  58. A. Khan, M. Safdar, M. M. A. Khan, K. N. Khattak, and R. A. Anderson, “Cinnamon improves glucose and lipids of people with type 2 diabetes,” Diabetes Care, vol. 26, no. 12, pp. 3215–3218, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Crawford, “Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial,” Journal of the American Board of Family Medicine, vol. 22, no. 5, pp. 507–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Anand, K. Y. Murali, V. Tandon, P. S. Murthy, and R. Chandra, “Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats,” Chemico-Biological Interactions, vol. 186, no. 1, pp. 72–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  61. W. Kim, L. Y. Khil, R. Clark, S. H. Bok, E. E. Kim, and S. Lee, “Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4,” Diabetologia, vol. 49, no. 10, pp. 2437–2448, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Imparl-Radosevich, S. Deas, M. M. Polansky et al., “Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling,” Hormone Research, vol. 50, no. 3, pp. 177–182, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. J. J. Dugoua, D. Seely, D. Perri et al., “From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark,” Canadian Journal of Physiology and Pharmacology, vol. 85, no. 9, pp. 837–847, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. C. Li, J. X. Shi, Q. R. Li, and S. J. Dai, “Clinical effect of Yu-quan pills in treatment of 18 diabetic patients,” Zhong Cheng Yao, vol. 2, pp. 17–18, 1984 (Chinese). View at Google Scholar
  65. Y. Zheng and D. Q. Huang, “Effects of Yuquan Wan on the index of kidney injure of early diabetic nephropathy,” Xia Dai Zhong Yao Yan Jiu Yu Shi Jian, vol. 19, pp. 42–44, 2005 (Chinese). View at Google Scholar
  66. C. Peng and C. H. Zheng, “Effect of Yuquan Wan on insulin sentivity in patients with type 2 diabetes,” Hubei Zhong Yi Zha Zhi, vol. 30, pp. 11–12, 2008 (Chinese). View at Google Scholar
  67. Y. Q. Deng, X. F. Fan, and G. L. Wu, “Effect of yuquan pill on proinflammatory cytokines in patients with type 2 diabetes mellitus,” Zhongguo Zhong xi yi jie he za zhi, vol. 26, no. 8, pp. 706–709, 2006 (Chinese). View at Google Scholar · View at Scopus
  68. H. G. Duan, Y. H. Wei, B. X. Li, D. M. Zhang, J. W. Zhang, and X. A. Wu, “Effects of Yuquan pills on pharmacokinetics of metformin hydrochloride in diabetic rats,” Zhongguo Zhongyao Zazhi, vol. 33, no. 18, pp. 2133–2139, 2008 (Chinese). View at Google Scholar · View at Scopus
  69. L. Liu, “Observation of the effects of Zhong-Hui Tangmaikang Jiaonang in treatment of 60 patients of type 2 diabetes,” Shanghai Yi Yao, vol. 21, pp. 21–23, 2000 (Chinese). View at Google Scholar
  70. M. Zhang, H. H. Yu, and X. P. Ding, “Observations of the effects of Zhong-Hui Tangmaikang in treatment of 30 cases of type 2 diabetic patients,” Gansu Zhong Yi, vol. 2, p. 21, 2001 (Chinese). View at Google Scholar
  71. X. Li, W. H. Gao, and Y. P. Wu, “Influence of Tangmaikang Jiaonang in insulin resistance in type 2 diabetic patients,” Hebei Zhong Yi, vol. 26, pp. 180–181, 2004 (Chinese). View at Google Scholar
  72. Y. F. Zhang, “Observation of curative effect of Kelening in type 2 diabetic patients with sulfonylurea failure,” Yi Nan Bing Za Zhi, vol. 3, pp. 25–26, 2004 (Chinese). View at Google Scholar
  73. Q. A. Zhang, H. P. Wang, and X. B. Liu, “Influence of Tangmaikang gralnule in blood lipids in senile diabetic patiens,” Yi Yao Dao Bao, vol. 19, p. 162, 2000 (Chinese). View at Google Scholar
  74. X. Y. Li, “Investigation into the effects of Tangmaikang Jiaonang in treatment of diabetic peripheral nepheropathy,” Chengdu Zhong Yi Yao Da Xue Xue Bao, vol. 28, pp. 46–47, 2005 (Chinese). View at Google Scholar
  75. B. Lin, “Tangmaikang in treatment of 60 patients of NIDDM,” Jilin Zhong Yi Yao, vol. 1, p. 31, 1999 (Chinese). View at Google Scholar
  76. Z. G. Chen and R. Chen, “The clinical observation of 68 cases of type 2 diabetic mellitus treated by Taimaikang Granule,” Zhongguo Yi Yao Dao Kan, vol. 12, no. 5, pp. 787–788, 2010 (Chinese). View at Google Scholar
  77. W. Du, J. Z. Guo, and J. Jin, “Observations of effects of Tangmaikang combined with metformin in treatment of newly diagnosed type 2 diabetes,” Ningxia Yi Ke Da Xue Xue Bao, vol. 32, pp. 93–94, 2010 (Chinese). View at Google Scholar
  78. Y. Zhang, L. X. Cheng, H. X. Liu, H. Y. Li, and X. F. Meng, “Clinical observations of Tangmaikang Keli in treatment of diabetic peripheral neuropathy,” Zhongguo Dang Dai Yi Yao, vol. 17, pp. 97–98, 2010 (Chinese). View at Google Scholar
  79. J. T. Zhou, T. H. Lin, and Z. Z. Zhou, “Clinical observations of Tangmaikang in treatment of 60 cases of type 2 diabetic patients,” Zhongguo Shi Yong Yi Yao, vol. 4, pp. 107–108, 2009 (Chinese). View at Google Scholar
  80. R. Zhou, J. J. Guo, C. M. Yin, and T. K. Li, “Clinical observations of Xiaoke Wan in treatment of type 2 diabetic patients (Qi and Yin deficiency zheng),” Zhongguo Yao Wu Yu Lin Chuang, vol. 3, pp. 131–132, 2003 (Chinese). View at Google Scholar
  81. H. Z. Zhang, “Clinical observation into Xiaoke Wan in the treatment of 86 cases of type 2 diabetic patients,” Zhong Yi Yao Yan Jiu, vol. 15, pp. 19–21, 1999 (Chinese). View at Google Scholar
  82. Y. C. Zhao and M. Hou, “Xiaoke Wan in treatment of 200 cases of type 2 diabetic patients,” Changchun Zhong Yi Xue Yuan Xue Bao, vol. 14, p. 15, 1998 (Chinese). View at Google Scholar
  83. G. Chen, Y. D. Ni, X. M. Lai, and H. Q. Liang, “Clinical study on Xiaoke Wan in treating type 2 diabetes mellitus with Qi and Yin Defiency,” Zhong Yao Xin Yao Yu Lin Chuang Yao Li, vol. 14, no. 2, pp. 84–86, 2003 (Chinese). View at Google Scholar
  84. J. L. Wu, “Observations into the effects of Xiaoke Wan in treatment of diabetes,” Shi Yong Zhong Xi Yi Jie He Lin Chuang, vol. 5, pp. 18–19, 2005 (Chinese). View at Google Scholar
  85. S. Li, “Effects of Xiaoke Wan on serum adiponectin levels in patients with type 2 diabetes mellitus,” International Journal of Traditional Chinese Medicine, vol. 32, no. 2, pp. 112–114, 2010 (Chinese). View at Google Scholar
  86. Y. Qu and L. Zhang, “Analysis of 36 severe low blood sugar reactions of Xiaokewan,” Zhongguo Yao Wu Jing Jie, vol. 6, pp. 99–101, 2009 (Chinese). View at Google Scholar
  87. N. Zhou and B. K. Peng, “Clinical effect evaluation of Jinqi Jiangtang Pian in treatment of type 2 diabetic patients,” Yunnan Zhong Yi Zhong Yao Za Zhi, vol. 20, p. 15, 1999 (Chinese). View at Google Scholar
  88. W. Y. Gu, “Clinical observation of Jinqi Jiangtang Pian combined with glibenclamide in treatment of type 2 diabetic patients,” Tianjin Yi Ke Da Xue Xue Bao, vol. 10, pp. 87–89, 2004 (Chinese). View at Google Scholar
  89. P. L. Shen, “Hypoglycemic and lipid-regulating effects of Jinqi Jiangtang Pian in type 2 diabetic patients,” Tianjin Yi Yao, vol. 33, p. 803, 2005 (Chinese). View at Google Scholar
  90. S. J. Ma, Y. H. LV, D. Chen, and Z. W. Wang, “Protective effects of Jinqi Jiangtang Pians in the kidney in the early stage of diabetic nephropathy,” Sichuang Zhong Yi, vol. 22, pp. 39–40, 2004 (Chinese). View at Google Scholar
  91. H. Y. Qian, “Clinical observations of effects of Jinqi Jiantang Pian in treatment of type 2 diabetes,” Jlin Yi Xue, vol. 31, p. 2212, 2010 (Chinese). View at Google Scholar
  92. H. Cao, M. Ren, L. Guo et al., “JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial,” Trials, vol. 11, article 27, 2010. View at Publisher · View at Google Scholar · View at Scopus
  93. Z. F. Shen, “Pharmacological basis on anti-diabetic activities of Jinqi Jiangtang Pian,” Guo Wai Yi Xue, vol. 24, no. 3, pp. 215–216, 2004 (Chinese). View at Google Scholar
  94. X. Y. Lai, “Observation into the therapeutic effects of Jiangtangjia Pian in treatment of 48 cases of type 2 diabetic patients,” Jiangxi Zhong Yi Yao, vol. 30, p. 50, 1999 (Chinese). View at Google Scholar
  95. Y. L. Liu and C. S. Li, “Kelening in treatment of 30 cases of type 2 diabetic patients with Qi and Yin deficiency,” Shandong Zhong Yi Za Zhi, vol. 15, pp. 302–303, 1996 (Chinese). View at Google Scholar
  96. P. Zhou, “Clinical study of glibenclamide in combination with kelening treatment in type 2 diabetic patients,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 17, pp. 29–31, 1997 (Chinese). View at Google Scholar
  97. H. J. Yang, L. Yao, and J. F. Hua, “Kelening in management of 30 cases of NIDDM,” Shanghai Zhong Yi Yao Za Zhi, vol. 9, p. 13, 1997 (Chinese). View at Google Scholar
  98. C. Zhang, “Tangmaikang in treatment of insulin resistance in 26 diabetic patients,” Jiang Su Zhong Yi Yao, vol. 25, p. 44, 2004 (Chinese). View at Google Scholar
  99. B. R. Gong, Z. P. He, Y. S. Fang, and L. Y. Zhu, “Pharmacodynamics effects of Jiangtangjia Pian,” Shi Yan Dong Wu Ke Xue Yu Guan Li, vol. 19, no. 2, pp. 45–46, 2002 (Chinese). View at Google Scholar
  100. Y. P. Yang and W. Z. Huang, “Drug efficacy study of Thirst Reliever capsule,” Xian Dai Zhong Xi Yi Jie He Zha Zhi, vol. 16, pp. 2826–2827, 2007 (Chinese). View at Google Scholar
  101. L. M. Fang, T. W. Zhang, H. J. Zhuang, and H. Li, “Clinical observation on Xiaotangling in treatment of type 2 diabetic patients,” Guiyang Yi Xue Yuan Xue Bao, vol. 28, pp. 337–338, 2003 (Chinese). View at Google Scholar
  102. J. X. Liu, “44 cases of diabetes mellitus with Qi, Yin deficiency and Yu treated with Xiaotangling Jiaonang,” Zhongguo Yao Ye, vol. 14, no. 9, p. 79, 2005 (Chinese). View at Google Scholar
  103. Z. M. Lu, Q. H. Cao, Y. L. Yang, and W. H. Jia, “Clinical observation on Xiaotangling Jiaonang combined with dimethyldiguanide in treating 150 cases of type 2 diabetes mellitus,” Hebei Zhong Yi, vol. 24, pp. 563–565, 2002 (Chinese). View at Google Scholar
  104. Y. S. Wang, X. H. Su, W. D. Li, X. Y. Wang, F. S. Tian, and Y. X. Li, “Clinical and experimental studies on Xiaotangling Jiaonangs in insulin resistance of type 2 diabetes mellitus,” Zhongguo Zhong Yi Yao Xing Xi Za Zhi, vol. 10, pp. 17–19, 2003. View at Google Scholar
  105. G. Sun, Z. L. Hu, and Z. Z. Lin, “Clinical observation on 35 cases of type 2 diabetic patients treated with Shenqi Jiangtang Keli,” Fujian Zhong Yi Xue Yuan Xue Bao, vol. 9, pp. 14–15, 1999 (Chinese). View at Google Scholar
  106. Z. D. Ye and J. J. Wu, “Analysis of therapeutic effect on type 2 diabetes mellitus treated by Shenqi Jiangtang Granule,” Zhongguo Shi Yong Nei Ke Zha Zhi, vol. 25, pp. 788–789, 2009 (Chinese). View at Google Scholar
  107. H. C. Gu, “Clinical observation of Shenqi Jiangtang Keli in treatment of 235 cases of type 2 diabetes,” Shandong Yi Yao, vol. 48, p. 116, 2008 (Chinese). View at Google Scholar
  108. Z. X. Yu, “Evaluation of efficacy of Shenqi Jiangtang Keli in 38 Cases of diabetic patients with secondary-failure to sulfonylureas,” Gong Qi Yi Kan, vol. 16, no. 5, pp. 3–4, 2003 (Chinese). View at Google Scholar
  109. X. L. Zhou and Y. Y. Sun, “Evaluation of actions of Shenqi Jiangtang Keli on glucose tolerance and pancreatic beta-islet function in patients,” Zhongguo Zhong Yi Ji Zheng, vol. 15, no. 4, pp. 369–370, 2006 (Chinese). View at Google Scholar
  110. R. W. Zhan, “Curative observation on 120 cases of type 2 diabetes mellitus in treatment of Yangyin Jiangtang Pian in combination with metformin,” Hebei Zhong Yi, vol. 26, pp. 748–749, 2004 (Chinese). View at Google Scholar
  111. P. Huang, M. H. Yang, W. Z. Gu, X. C. Yang, and G. M. Shao, “Experimental study on diabetic rat with hyperviscosity sysdrome treated with Yangyinjiangtang Tablet,” Zhongguo Zhong Yi Ke Ji, vol. 8, no. 6, pp. 349–351, 2001. View at Google Scholar
  112. D. P. Lei and Y. Q. Li, “Clinical and experimental studies of Xiaoke Jiangtang Pian in treatment of diabetes mellitus,” Zhong Cheng Yao, vol. 11, p. 2, 1988 (Chinese). View at Google Scholar
  113. G. T. Yin and R. H. Cui, “Yijin jiangtang capsules for treatment of 42 patients with diabetes type II,” Xinxiang Yi Xue Yuan Xue Bao, vol. 20, pp. 372–374, 2003 (Chinese). View at Google Scholar
  114. Y. J. Li and H. X. Xu, “Research progress on anti-diabetic Chinese Medicines,” Zhong Yao Cai, vol. 29, pp. 621–625, 2009. View at Google Scholar
  115. J. Li, “Thinking on syndrome differentiation treatment and personalized therapy for tumor,” Journal of Chinese Integrative Medicine, vol. 7, no. 4, pp. 306–308, 2009. View at Publisher · View at Google Scholar · View at Scopus